Pseudotumor cerebri natural history, complications and prognosis: Difference between revisions
Created page with "__NOTOC__ {{Pseudotumor cerebri}} {{CMG}}; {{AE}} ==Overview== If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifesta..." |
No edit summary |
||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
==Natural History, Complications, and Prognosis== | ==Natural History, Complications, and Prognosis== | ||
===Natural History=== | ===Natural History=== | ||
The symptoms of pseudotumor cerebri usually develop in the mean age of 31 mostly in obese women with headache as the most common presenting sign. the other symtoms of increased intracranial pressure may develop in patients sych as | |||
===Complications=== | ===Complications=== |
Revision as of 17:23, 30 July 2018
Pseudotumor cerebri Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pseudotumor cerebri natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Pseudotumor cerebri natural history, complications and prognosis |
FDA on Pseudotumor cerebri natural history, complications and prognosis |
CDC on Pseudotumor cerebri natural history, complications and prognosis |
Pseudotumor cerebri natural history, complications and prognosis in the news |
Blogs on Pseudotumor cerebri natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Natural History, Complications, and Prognosis
Natural History
The symptoms of pseudotumor cerebri usually develop in the mean age of 31 mostly in obese women with headache as the most common presenting sign. the other symtoms of increased intracranial pressure may develop in patients sych as
Complications
- Common complications of [disease name] include:
- [Complication 1]
- [Complication 2]
- [Complication 3]
Prognosis
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
- Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.